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MR spectroscopyAbstract Background and purpose: Pre-operative imaging has a major role in surgical planning of
parotid gland tumors.
Aim: To assess the role of the combined techniques of ADC generated from DWI and MR spec-
troscopy in identiﬁcation of various pathological subtypes of parotid gland tumors.
Patients and methods: Prospective study was conducted on 25 patients with primary parotid
tumors (11 males, 14 females, age ranged 22–79 years with mean of 53.4 ± 13.6 years). DWI and
MRS were performed for all patients and the results were correlated with histopathological
ﬁndings.
46 A.A. Salama et al.Results: The 18 (72%) benign and 7 (28%) malignant tumors consisted of 11 pleomorphic adeno-
mas, 7 Warthin tumors, and 7 malignant tumors. The mean ADC value for pleomorphic adenomas
was 1.89 ± 0.18 · 103 mm2/s, for Warthin tumors was 0.92 ± 0.22 · 103 mm2/s, and for the
malignant tumors was 1.03 ± 0.13 · 103 mm2/s, signiﬁcant difference was seen between benign
and malignant tumors (P = 0.037). The mean values of Cho/Cr ratios were 3.37 ± 0.78,
5.9 ± 1.75 and 1.72 ± 0.41, for pleomorphic adenomas, Warthin tumors, and malignant tumors,
respectively. Difference was signiﬁcant between benign and malignant tumors (P= 0.001).
Conclusion: DWI and MRS are useful noninvasive diagnostic modalities in identiﬁcation of vari-
ous pathological subtypes of parotid tumors.
 2014 The Egyptian Society of Radiology and Nuclear Medicine. Production and hosting by Elsevier
B.V. Open access under CC BY-NC-ND license.1. Introduction
Salivary gland neoplasms represent the most complex and
diverse group of tumors encountered by the head and neck
oncologist. Their diagnosis and management are complicated
by their relative infrequency (3% of head and neck tumors)
(1). However, the great variety of histological types makes
them a major challenge for radiologists and clinicians (2).
Fine-needle aspiration cytology (FNAC) is a minimally
invasive procedure used in the preoperative diagnosis of paro-
tid gland tumors; however the results of FNAC are not always
conclusive because insufﬁcient specimens are sometimes
obtained because of a small sample size or because of the deep
location of the tumor (3,4). Therefore, pre-operative imaging
has a major role in surgical planning (2).
CT andMRI are the usual investigations used for evaluating
known or suspected salivary gland masses. Imaging cannot dis-
tinguish between different histologic types as all tumors are
isoattenuating to glandular parenchymaonCTandhypointense
to gland on T1 W MR image and all of them enhance on post
contrast CT and MR images. However, both the modalities
can sensitively differentiate between solid and cystic lesions (5).
New magnetic resonance imaging (MRI) techniques such as
diffusion weighted imaging (DWI) and proton magnetic reso-
nance spectroscopy (1H-MRS) have shown promising results
in the differentiation between benign and malignant salivary
gland tumors (6,7).
Diffusion-weighted imaging (DWI) with magnetic reso-
nance relies upon the relative diffusivity of water protons
within the tissue. This technique is based on the amount of
random (Brownian) motion that water protons undergo (8).
Celebi et al., concluded that DW-MRI may be useful for dis-
tinguishing between pleomorphic adenomas and other parotid
masses (9).
In normal tissue or in areas exhibiting vasogenic edema, the
motion of water molecules is not limited and no restricted dif-
fusion should be noted. In tissues with cytotoxic edema or in
highly cellular regions, however, there is a diffusion restriction,
which can be measured both qualitatively and quantitatively
(10). Hypercellular tissue, as occurring within malignant
tumors, will show low ADC values. Non-tumoral tissue
changes such as edema, inﬂammation, ﬁbrosis and necrosis
are expected to show low cellularity, in strong contrast with
viable tumor, this results in high ADC values. An inverse cor-
relation between the ADC value and tumor cellularity in
experimental models has been shown, and this was clinically
validated (11,12).Eida et al., (13) studied ADC mapping of salivary gland
tumors and concluded that ADC can provide preoperative tis-
sue characterization of salivary gland tumors.
The use of proton MR spectroscopy as a differentiating tool
as a general, based upon the idea that a high Cho/Cr ratio is tied
to a high cellular membrane turnover in malignant lesions. Typ-
ical spectral patterns associated with cancer include an increase
in the total choline (Cho, 3.2 ppm) signal intensity (SI) relative to
creatine (Cr, 3.02 ppm), often coupledwith the presence of other
metabolites, including lactate (Lac, 1.3 ppm) (14,15).
Choline and its derivatives are thought to originate from
phospholipid metabolism of cell membranes. The ﬁnding of
higher Choline metabolite levels indicates an increase in cell
proliferation and membrane biosynthesis in tumors. Similar
results have been obtained from prostate, brain, colon, breast,
thyroid, adrenal and neck masses and it is possible that it can
be used as a marker for active cellular proliferation. (16-18)
2. Aim of the work
The purpose of this study was to assess the role of the com-
bined techniques of apparent diffusion coefﬁcient (ADC) gen-
erated from diffusion-weighted magnetic resonance imaging
(DWI) and metabolite spectrum acquired by magnetic reso-
nance spectroscopy (MRS) in the identiﬁcation of various
pathological subtypes of parotid gland tumors.3. Patients and methods
3.1. Participants
This prospective study was conducted in accordance with the
recommendations of the local ethics committee of Tanta Uni-
versity that approved it. Written informed consent was signed
by all the included patients. Between February 2013 and May
2014, 25 (25) consecutive patients (11 males, 14 females; aged
from 22 to 79 years; mean age was 53.4 ± 13.6 years) with a
clinically suspected primary tumor of the parotid gland were
examined prospectively before surgery. Before MR imaging,
all patients underwent ultrasonography to conﬁrm the sus-
pected clinical diagnosis. As part of the study protocol, none
of the included patients had ﬁne-needle aspiration biopsy
(FNAB) before MR imaging to avoid disturbance of the lesion
metabolites by hemorrhage or trauma.
Patientswere referred to theMRIunit at theTanta university
hospital from theGeneral SurgeryDepartment. All tumorswere
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mal period between MR imaging and surgery was 15 days (ran-
ged from1 to 15 days; themeanwas 4.7 ± 2.3 days). In 20 of the
25 patients (9 males, 11 females; mean age, 52.8 ± 15.3 years),
we obtainedMR images of the healthy parotid as control. Cases
that were under chemo or radiotherapy or had a tumor smaller
than 1 cm3 were excluded from our study.
3.2. Methodology
All patients included in the study were subjected to:
 Full history taking,
 Thorough clinical examination,
 Parotid ultrasound,
 Routine laboratory investigations in the form of: CBC, liver
and kidney function tests, fasting and 2 h postprandial
blood glucose.
3.2.1. MR imaging
After exclusion of contraindications, all participants were sub-
jected to 1.5-T 1H-MR spectroscopy (at echo-times (TE) 144
and 35 ms) and diffusion-weighted imaging (b value 250 and
1000 s/mm2).
All MR imaging and 1H-MRS studies were performed
using a 1.5 T system (Signa; GE Medical Systems, Milwaukee,
WI, USA) with a neurovascular coil (NV array). The routine
imaging studies included multiplanar T2-weighted fast spin-
echo (4000/126/2) with an echo train length of eight sequences.
Optimal water resonance suppression was achieved. The
parameters usedwere 2000/270, 192 acquisitions, a spectral width
of 2500 Hz, and 2048 data points for all patients. In all patients,
MR spectra were obtained with a TE of 144 with additional TE
35. The acquisition time for each sequence was 7 min 54 s.
Fast spin-echo images were transverse T2-weighted MR
images. 1H-MRSwas performed by a multivoxel long and short
echo (TE, 144 and 35 ms) point-resolved spatially localized
spectroscopy. The area of interest in all patients was the parotid
gland. The section thickness was 20 mm, and the anterior-to-
posterior and right-to-left dimensions were 30 · 30 mm.
Metabolites of biologic importance, choline (Cho) and cre-
atine (Cr) were detected by this technique.
The multivoxel MRS data were processed by the spectro-
scopic analysis package on the workstation. The resonances
of main metabolites were quantiﬁed as follows: the Cr peak
at 3.02 ppm, the Cho peak at 3.20 ppm, and the Lac doublet
at 1.33 ppm.
The ratio of Cho/Cr was measured in cases with detected
choline.
3.2.2. Diffusion-weighted imaging and apparent diffusion
coefﬁcient mapping (ADC)
Diffusion-weighted imaging was performed in the transverse
plane by using an SE echo-planar imaging sequence with the
following parameters: TR/TE/TI (inversion time), 12,000/95/
2200 ms; diffusion gradient encoding in three orthogonal
directions; b= 1000 and 250 s/mm2; FOV, 24 · 40 cm; matrix
size, 128 · 256 pixels; section thickness, 5 mm; section gap,
2.5 mm. An ADC map was obtained. In the quantitative study,
an imaging slice was chosen; ﬁve (1–2 cm) circular regions ofinterest were located on the parotid mass, mean ADC value
is calculated for benign and malignant masses. ADC of each
mass was measured using a circular region of interest.
Twenty normal parotid glands of our patients were also
evaluated for ADC values as control.
The sensitivity, speciﬁcity, PPV, and NPV of DWI and MR
spectroscopy were calculated for each technique separately and
after application of both techniques together.
The readers of the diffusion WI was blinded to the MRS
results primarily.
3.2.3. Surgical methods
Superﬁcial conservative parotidectomy was performed for all
patients with benign tumors (n= 18). Wide local excision with
total conservative parotidectomy and modiﬁed block neck dis-
section was performed for ﬁve patients with malignant tumors.
For the two patients with facial nerve inﬁltration; total parot-
idectomy with facial nerve scariﬁcation and modiﬁed block
neck dissection was performed.3.2.4. Histopathological examination
Surgical specimens were ﬁxed in 10% formalin solution and
embedded in parafﬁn. Serial 4 lm sections were made and
stained with hematoxylin and eosin (H&E). Histopathological
diagnosis of the surgical specimens was obtained and used as
the gold standard diagnosis. Findings of DWI and MR spec-
troscopy were correlated with histopathological diagnosis.
3.3. Statistical analysis
All statistical analyses were computed with the Statistical
Package for the Social Sciences (SPSS) Version 16. ADC val-
ues for each histologic subtype were achieved by taking the
mean of the separate mean values of each tumor per patient.
For comparison of different histologic types of parotid gland
tumors, an unpaired 2-tailed Student t-test was used. Sensitiv-
ity, speciﬁcity, positive predictive value, negative predictive
value and accuracy were used for diagnostic test evaluation.
The level of signiﬁcance was adopted at P< 0.05.4. Results
Prospective study was conducted on 25 patients with parotid
gland masses (11 males = 44% of cases and 14
females = 56% of cases; age ranged from 22 to 79 years; mean
age was 53.4 ± 13.6 years). Most of patients (76%) presented
by swelling in the area of affected parotid gland. 5 patients
(20%) had associated pain (one patient with benign lesion
and four with malignant lesions). One patient (4%) with muco-
epidermoid carcinoma presented with skin involvement. We
observed affection of facial nerve in 2 cases (8%), which were
malignant tumors. On physical examination, 2 patients (8%)
presented palpable cervical nodes and 2 cases presented by
bulging the lateral wall of the oropharynx. Gender, age and
the clinical presentations are showed in Table 1.
Table 2 shows different histopathological types of parotid
masses included in this study and their corresponding mean
ADC values.
The benign masses were 18 (72%). The most common
benign tumors were pleomorphic adenomas (61.12% of benign
Table 1 Descriptive characteristics and clinical presentations











-Facial nerve palsy 2 (8)
-Skin involvement 1 (4)
-Enlarged cervical lymph nodes 2 (8)
-Lateral pharyngeal wall bulging 2 (8)
NB. More than one clinical presentation was found in one patient.
Fig. 1 (A-F): Warthin tumor of the right parotid gland. (A, B)
T2 WI shows space occupying multiple cystic lesions within the
right parotid gland displaying high signal intensity (SI). (C, D)
DWI reveals high SI. (E) ADC map shows intermediate mean
value (1.7 ± 0.55 · 103) denoting cystic changes. (F) MRS shows
choline peak at 3.2 ppm and creatine peak at 3.02 ppm with high
choline/creatine ratio (5.57).
48 A.A. Salama et al.tumors), followed by Warthin tumor (38.88% of benign
tumors). The malignant tumors were 7 (28%). The most com-
mon malignant tumors were mucoepidermoid carcinomas rep-
resenting 71.43% off all malignant tumors and, being more
frequently seen in males.
4.1. DWI with ADC mapping ﬁndings
The mean ADC value of healthy parotid glands was
0.53 ± 0.15 · 103 mm2/s. Spectra were successfully acquired
from all normal parotid glands that showed the presence of lip-
ids but no detectable levels of Cho or Cr.
The mean ADC value for pleomorphic adenomas was
high (1.89 ± 0.18 · 103 mm2/s). Six cases with Warthin
tumors showed low mean ADC value (0.92 ± 0.22 ·
103 mm2/s); the remaining case showed an intermediate
mean ADC value (1.7 ± 0.55 · 103) denoting cystic changes
Fig. 1-E. Generally there was statistically signiﬁcant differ-
ence between pleomorphic adenomas and Warthin tumors
on the basis of mean ADC values (P= 0.001) (see Figs. 2
and 3).
The mean ADC value for malignant tumors was
1.03 ± 0.13 · 103 mm2/s. The malignant masses showed low
ADC values (0.6–<1.2 · 103 mm2/s) in 6 masses, and inter-
mediate value (1.76 ± 0.11 · 103 mm2/s) in one case with aci-
nic cell carcinoma Fig. 4-C. Carcinomas were not
differentiable from Warthin tumors on the basis of ADC val-
ues solely with statistically insigniﬁcant difference (P= 0.163),
in this condition morphological patterns on conventional MRI
and metabolic spectra on MRS differentiated them. The
detailed signiﬁcance levels are given in Table 4.Table 2 Different histopathological types of parotid masses includ
Type of masses No. (%) Histopathological types of parotid m
Benign masses 18 (72) Pleomorphic adenomas (n= 11)
Warthin tumors (n= 7)
Malignant masses 7 (28) Mucoepidermoid carcinomas (n= 5
Adenoid cystic carcinoma (n= 1)
Acinic cell carcinoma (n= 1)4.2. MR spectroscopy ﬁndings
Spectra were successfully obtained in most parotid gland
masses and all normal parotid glands. In less than 10% of
patients in our study, spectroscopy was unsuccessful as a result
of patient motion during data acquisition. Cho was present on
the successfully obtained spectra of all benign and malignant
lesions acquired with either echo time. At an echo time ofed in this study and their corresponding mean ADC values.
asses (n= 25) Mean ADC value · 103 mm2/sec
1.89 ± 0.18
0.92 ± 0.22
) 0.99 ± 0.15
0.84 ± 0.07
1.72 ± 0.11
Fig. 2 (A-E): Pleomorphic adenoma of the right parotid gland.
(A) T2WI shows a well circumscribed solid mass in the right
parotid gland displaying moderate to high SI. (B) DWI reveals an
intermediate SI. (C) ADC map shows an intermediate mean value
(1.6 ± 0.1 · 103). (D) MRS reveals choline peak at 3.2 ppm and
creatine peak at 3.02 ppm with choline/creatine ratio 2.2.
Fig. 3 (A-E): Mucoepidermoid carcinoma of the left parotid
gland. (A & B) T2 WI show an ill-deﬁned low to moderate SI mass
lesion destructing and replacing the left parotid gland. (C) DWI
reveals high SI. (D) ADC map shows low ADC value
(0.93 ± 0.35 · 10–3). (E) MRS reveals choline peak at 3.2 ppm
and creatine peak at 3.02 ppm with choline/creatine ratio 1.3.
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5.9 ± 1.75 and 1.72 ± 0.41, for pleomorphic adenomas, War-
thin tumors, and malignant tumors; respectively Table 3.
Differences were signiﬁcant between Warthin tumors and
pleomorphic adenomas (P= 0.023) and between benign and
malignant parotid tumors (P= 0.001) .The P values obtained
in the comparison of mean Cho/Cr between different tumor
groups are shown in Table 4.
4.3. Histopathological ﬁndings
4.3.1. Pleomorphic adenoma (11 cases)
Examination revealed the presence of admixture of epithelial
cells, myoepithelial cells, and mesenchymal elements. The epi-
thelial components were formed of tubules, trabeculae, kerati-
nizing and non-keratinizing squamous cell nests, or mucous
cysts. Ductal structures were composed of epithelial and myo-
epithelial components. The stromal component was mucoid/
myxoid in 7 cases, cartilaginous in 3 cases, and hyalinized in
one case (see Table 5).
4.3.2. All cases of Warthin tumors (7 cases)
All cases of Warthin tumors (7 cases) were sharply demarcated
with a thin capsule, and composed of cystic and solid areas
with papillary structures projected into the lumina. The epithe-
lium consisted of two layers of cells: the oncocytic luminal cells
which exhibited palisading of their bland elongated nuclei.
Inner to this layer, was the basal cells.4.3.3. Mucoepidermoid carcinoma (5 cases)
Mucoepidermoid carcinoma (5 cases) characterized by the
presence of multiple cell types in a multicystic conﬁguration.
The most common were squamous, mucous, cuboidal interme-
diate, and basaloid cells.
4.3.4. Adenoid cystic carcinoma (one case)
Three patterns were observed: The cribriform pattern consisted
of basaloid epithelial cells forming sharply demarcated nests
containing multiple extracellular spaces ﬁlled with eosinophilic
hyaline-like material. The tubular pattern was characterized by
the presence of small well-formed ducts and tubules. The solid
pattern was found admixed with one of the other variants.
4.3.5. Acinic cell carcinoma (one case)
Acinar tumor cells resemble the serous cells of the normal par-
otid gland with ﬁnely granular basophilic cytoplasm. Other
types of cells were also seen.
Fig. 4 (A-E): Acinic cell carcinoma of left parotid gland. (A) T2
WI shows an ill-deﬁned moderate to high SI mass destructing and
replacing the left parotid gland. (B) DWI reveals high SI. (C) ADC
map shows intermediate mean value (1.76 ± 0.11 · 103) denot-
ing areas of degeneration. (D) MRS reveals choline peak at
3.2 ppm and creatine peak at 3.02 ppm with choline/creatine
ratio 1.4.
Table 3 Correlation between choline/creatine ratios and
histopathological results.
Tumor Ch/Cr ratio (Mean ± SD)
Pleomorphic adenomas (n= 11) 3.37 ± 0.78
Warthin tumors (n= 7) 5.9 ± 1.75
Mucoepidermoid carcinomas (n= 5) 1.54 ± 0.14
Adenoid cystic carcinoma (n= 1) 1.87
Acinic cell carcinoma (n= 1) 2.23






Warthin tumors & pleomorphic adenomas 0.001* 0.023*
Pleomorphic adenomas & malignant tumors 0.003* 0.014*
Warthin & malignant tumors 0.163 <0.001*
Benign & malignant tumors 0.037* <0.001*
* Statistically signiﬁcant difference (P 6 0.05).
Table 5 Diagnostic value of MRS, diffusion study and
combined techniques with histopathological correlations.
Technique Sensitivity Speciﬁcity PPV NPV Accuracy
Quantitative diﬀusion 85 95 96 82 90
MRS 90 100 100 92 92
Diﬀusion and MRS 95 100 100 96 98
50 A.A. Salama et al.5. Discussion
Not only distinguishing between benign or malignant lesions
but also determining the deﬁnite histological subtypes of pri-
mary tumors of parotid gland is so important for the selection
of appropriate surgical approach preoperatively (19).
Most studies showed that the mean age is higher in malig-
nant tumors (about 55 years) compared to benign tumors
(about 45 years) (9,19-21). Our results conﬁrmed these ﬁnd-
ings; the mean age in our study was 46.23 years for benign
tumors and 59.44 years for malignancies. In this study there
was an overall female predominance, with a male to female
ratio of 1:1.27. This ﬁnding is different from other reports
(22,23). But the report of our study is similar to others as far
as an association between the male sex and malignant neo-
plasms and the female sex and benign neoplasms is concerned
(24).
The main complaint of patients with parotid tumors was a
lump in the parotid area. In two cases when parotid tumor
arose from the deep lobe of the gland, the tumor was bulging
the lateral wall of the oropharynx. Approximately 70% of
patients with malignant tumors manifested signs of malig-
nancy, such as pain, facial nerve affection, no mobility,
involvement of skin, increased parotid volume and lymphade-
nopathy. These results were similar to that reported by Mag
et al. (25).
In this study, we investigated the potential of combined
techniques of DWI with ADC mapping and metabolite spec-
trum acquired by magnetic resonance spectroscopy (MRS) in
differentiating various entities of parotid gland tumors. Our
results demonstrated that by using DWI only there was an
overlap between benign (Warthin tumors) and malignant
tumors while by using both DWI and MRS, diagnostic accu-
racy approached 100%. These results were in agreement with
the study conducted by Habermann et al. (6), who stated that
DWI has the potential to differentiate pleomorphic adenoma
and myoepithelial adenomas from all other examined entities.
Due to an overlap not only within the group of benign and
malignant lesions but also an overlap between these groups,
diagnoses should not be addressed on the basis of ADC values
solely. Therefore, further studies combining DWI, morpho-
logic criteria, and probably other MR imaging techniques
seem to be warranted.
Our results are in slight contrast to other studies dealing
with this speciﬁc topic (13,26-28). In the most recently pub-
lished one by Eida et al. (13) 31 consecutive patients with a sin-
gle tumor in the parotid or submandibular gland were
evaluated. The authors concluded that ADC may provide pre-
operative tissue characterization of salivary gland tumors by
using different b factors (500 and 1000 s/mm2). Our results also
were supported by Matsushima et al. (29) who reported that
ADC values alone are not sufﬁcient to differentiate benign
from malignant salivary gland tumors.
In our study, the mean ADC of malignant tumors
(1.03 ± 0.13 · 103 mm2/s) has been shown to be signiﬁcantly
smaller than that of pleomorphic adenomas
(1.89 ± 0.18 · 103 mm2/s) however there was an overlap
between the mean ADC values of Warthin tumors
(0.92 ± 0.22 · 103 mm2/s) and that of malignant tumors
(1.03 ± 0.13 · 103 mm2/s). These results are in agreement
with the study of Chawla et al. (30) who reported that the
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smaller than that of benign solid tumors and ADC values of
pleomorphic adenomas were signiﬁcantly higher than those
of all other entities; however the mean ADC value of Warthin
tumors was even smaller than that of malignant tumors. This
ﬁnding might be attributed to the intense lymphoid accumula-
tion in the stroma and proliferation of the epithelial compo-
nent leading to a decrease in the extracellular extravascular
space and therefore a decrease in ADC of Warthin tumors.
In a study provided by Yoshino et al. (27) (b factors, 0 and
771 s/mm2), the provided ADC value for a pleomorphic ade-
noma (n= 1) was 1.99 · 103 mm2/s, for Warthin tumors
(n= 2) was 0.89 · 103 mm2/s and for an acinic cell carci-
noma was (1.38 · 103 mm2/s), these values were similar to
that observed in our study. Regarding intermediate ADC value
of acinic cell carcinomas observed by Yoshino et al. (27) and in
our study might be explained by the fact that in the single aci-
nic cell carcinoma a cystic component was observed, which
might lead to a substantial increase of ADC. In our study,
other malignant tumors (n= 6) presented as solid tumors with
low ADC values.
In other studies (9,19,26), pleomorphic adenomas were dis-
tinguishable from all other examined entities solely on the
basis of the calculated ADC values. In our study, pleomorphic
adenomas were also distinguishable from all other entities.
From the point of view of a head and neck surgeon, this has
a higher impact, caused by the fact that pleomorphic adeno-
mas have a risk of malignant transformation (carcinoma ex
pleomorphic adenoma) and the surgical approach has to be
much more aggressive due to the high risk of recurrence
(e.g., lateral or complete parotid resection) with a higher risk
of facial nerve injury (31).
Warthin tumors, as the second most common benign
tumors of parotid glands, are treated much more conserva-
tively than pleomorphic adenomas and, of course, all malig-
nant lesions (32,33). A Warthin tumor treated by enucleation
has an expected recurrence rate of only 2% (32) Therefore, dif-
ferentiation from malignant lesions would be very helpful with
respect to the surgical approach. In our study, the mean ADC
value for Warthin tumors was 0.92 ± 0.22 · 103 mm2/s. This
ADC value was very close to that in all other studies dealing
with this topic (26,27). In contrast to our results, Ikeda et al.
(34) calculated the average ADC value of Warthin tumors
(0.96 · 103 mm2/s; n= 19) to be signiﬁcantly lower than that
in all included malignant lesions (1.19 · 103 mm2/s; n= 17).
Choline and its derivatives are thought to originate from
phospholipid metabolism of cell membranes. The ﬁnding of
higher Choline metabolite levels indicates an increase in cell
proliferation and membrane biosynthesis in tumors. Similar
results have been obtained from prostate, brain, colon, breast,
thyroid, adrenal and neck masses (16-18,35,36).
In the current study, the mean values of Cho/Cr ratios were
3.37 ± 0.78, 5.9 ± 1.75 and 1.72 ± 0.41, for pleomorphic ade-
nomas Warthin tumors, and malignant tumors, respectively.
Differences were signiﬁcant between Warthin tumors and pleo-
morphic adenomas (P= 0.023) and between benign and
malignant parotid tumors (P= 0.001). The Cho/Cr ratios in
all benign tumors were in the range of 2.4–7.3, and ratios in
all benign tumors were above those in malignant tumors, for
which the range was 1.13–1.85 Therefore, in this study by using
a value greater than 2.4, the sensitivity, speciﬁcity, negativepredictive value, and positive predictive value for predicting
a benign parotid mass were all 100%.
These results were in agreement with that found by King
et al. (7) who conducted a study on salivary gland tumors (9
malignant and 47 benign) and reported higher Cho/Cr in
benign salivary gland tumors as compared to malignant ones
and by using choline/creatine (Cho/Cr) ratios greater than
2.4 at an echo time of 136 ms, a distinction between benign
and malignant lesions is possible, while a ratio greater than
4.5 suggested the presence of a Warthin tumor. They have
attributed these results to the fact that an elevated Cho level,
which is a marker of membrane turnover, is found not only
in malignant tumors but also in benign tumors that are hyper-
cellular and in inﬂammatory processes (7). Dalia et al. stated
that MR spectroscopy should be used in the future as a com-
plementary method to routine MRI to differentiate between
benign and malignant neck masses (37). This ﬁnding was coin-
cided with our conclusion.
In our study, the diagnostic accuracy, sensitivity and spec-
iﬁcity of DWI with ADC mapping alone were 90%, 85% and
95%, compared to 92%, 90% and 100%, respectively by using
MRS. By using the combined techniques of DWI and MRS,
diagnostic accuracy approached 100%.
The major limitations of this study beside technical ones
were the application of these evaluation techniques only in lar-
ger lesions (more than 1 cm3). Also, a small number of cases
and lesions were included in this study as compared to the
large pathological entities of parotid gland tumors.
6. Conclusion
Combined MRS and diffusion WI are useful noninvasive diag-
nostic modalities for identiﬁcation of various pathological sub-
types of parotid gland tumors with excellent results that could
be used instead of FNAB. MRS and diffusion WI could be
included in the routine MR imaging protocol to evaluate par-
otid tumors and provide complementary information for con-
ventional structural MR imaging techniques. However more
studies with large numbers of pathological entities of parotid
gland tumors are required to validate our results.
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